Check Out ITeos Therapeutics Inc (ITOS)’s Trade Data Rather Than the Analysts’ Views

With 0.65 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.24 million shares. The 52-week range on ITOS shows that it touched its highest point at $18.13 and its lowest point at $4.80 during that stretch. It currently has a 1-year price target of $12.83. Beta for the stock currently stands at 1.51.

Price Performance and Earnings:

Three-month performance surged to 43.68% while six-month performance rose 30.21%. The stock lost -38.39% in the past year, while it has gained 30.21% so far this year. A look at the trailing 12-month EPS for ITOS yields -3.23 with Next year EPS estimates of -1.57. For the next quarter, that number is -0.89. This implies an EPS growth rate of 15.74% for this year and 44.03% for next year. EPS is expected to grow by 3.89% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -34.39%.

Float and Shares Shorts:

At present, 38.27 million ITOS shares are outstanding with a float of 35.88 million shares on hand for trading.

An Overview of Recent Financials:

Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. The EBITDA in the recently reported quarter was -$38797000.0 and diluted EPS was -$0.8.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for ITOS since 1 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$3.02124 being high and -$3.36395 being low. For ITOS, this leads to a yearly average estimate of -$3.1475.

Sete News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.